Overdose and anaphylaxis are two serious medical emergencies that require immediate intervention and can be fatal if not treated in time. Supplying every AED first-aid box with epinephrine ...
On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the treatment of opioid overdose. The treatment is used to treat opioid ...
BOSTON - The price of an injectable overdose-reversing drug designed for use by laypeople has skyrocketed, prompting outrage from first-responders, health advocates and elected officials. Kaléo, a ...
Kaléo rolled out two initiatives to increase access to its opioid overdose reversal drug Evzio, the company announced April 5. Here are four things to know. 1. Kaléo already covers out-of-pocket costs ...
The Food and Drug Administration is working to make naloxone more available, stated Karen Mahoney, MD, deputy director for the division of nonprescription drug products at the Center for Drug ...
Richmond, Virginia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it received the Prototype Innovation award ...
The US Food and Drug Administration (FDA) has announced new action to encourage companies to develop naloxone products for over-the-counter (OTC) use — or apply to switch certain products from ...
The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...
SILVER SPRING, Md., Aug. 7, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zurnai, the first nalmefene hydrochloride auto-injector for the emergency treatment of known or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback